None. In fact, for the company that I referenced, the final clinical trial we ran was actually going after an orphan indication. Had we been successful it's a product that wouldn't have been launched in Canada because it doesn't make economic sense.
Chair, Board of Directors, LifeSciences British Columbia
None. In fact, for the company that I referenced, the final clinical trial we ran was actually going after an orphan indication. Had we been successful it's a product that wouldn't have been launched in Canada because it doesn't make economic sense.
See context to find out what was said next.